Veterinary Medicines

Thyroxavet 200 microgram tablets for dogs and cats

Authorised
  • Anhydrous levothyroxine sodium
Download as PDF

Product identification

Medicine name:
Thyroxavet 200 microgram tablets for dogs and cats
Thyroxavet 200 mikrogramm tabletta kutyáknak és macskáknak A.U.V.
Active substance:
  • Anhydrous levothyroxine sodium
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Anhydrous levothyroxine sodium
    200.00
    microgram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH03AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Available in:
  • Hungary
Package description:
  • 25 Aluminium - PVC/Alu/oPA blisters of 10 tablets packed in cardboard box
  • 10 Aluminium - PVC/Alu/oPA blisters of 10 tablets packed in cardboard box

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 4269/X/21 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0325/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."